HAIN enters its May 8 earnings report with short sellers the most committed they have been all year — and Tuesday's 14% single-day collapse underlines why.
Short interest has become the defining feature of this setup. At 16.7% of the free float, it has climbed steadily from 14.2% in mid-March — a gain of roughly 2.5 percentage points in six weeks. The move accelerated sharply in late April, with shorts adding nearly a full percentage point of float in a single session around April 23. The ORTEX short score has held above 70 all week, a level that places HAIN in the most heavily shorted cohort in its universe. Twelve days to cover — per FINRA's fortnightly reading — means unwinding would be a slow process even if sentiment reversed.
The borrow market reflects the same directional pressure, though the cost of borrowing remains relatively modest. Cost to borrow has risen 54% over the past month to 1.36%, an elevated pace but still well within the range where supply is not genuinely constrained. Availability is still adequate — the lending pool has not been meaningfully exhausted, and the 52-week peak utilisation reading of 37% confirms shorts have faced no structural squeeze. The positioning looks more like an orderly build than a panicked pile-on.
Options traders, by contrast, are almost entirely sidelined on the downside. The put/call ratio is 0.135 — barely above its 20-day average of 0.13 and well below the 52-week high of 0.43. Call volume overwhelms puts by roughly 7-to-1. That divergence is striking: short sellers are building in size while the options market shows none of the protective hedging usually associated with a stock this distressed. Either options traders see limited incremental downside from here, or the instrument is simply too illiquid to express a view efficiently.
The Street offers no comfort for bulls. Every analyst who covers HAIN carries a hold or worse. Barclays downgraded to Underweight in mid-March, cutting its target to $0.50. At today's price of $0.64, the stock is already below most published targets — a data-consistency note: several targets in the $1.00–$1.50 range now appear stale relative to where the equity actually trades. The bear case is straightforward: organic revenue is contracting at high single digits, EPS estimates have been revised down repeatedly, and a stretched balance sheet limits the company's room to invest behind its brands. The bull case rests on potential efficiency gains and a valuation that, at a price-to-book of 0.08, prices in near-total impairment of the business. EV/EBITDA at 8.2x remains the one multiple that does not scream distress — but that multiple has been compressing steadily.
The most instructive data point ahead of the May 8 print is what happened last time. At the February 9 earnings, HAIN fell 27% on the day and extended that to -28% by the end of the week. Short interest at that point was already elevated, yet the stock still moved violently through what was presumably a crowded short base — a reminder that heavily shorted, heavily sold micro-cap names can generate outsized two-way moves at results. Castleknight Management, which entered Q1 as the largest disclosed institutional holder at 8.3% of shares, has the most at stake.
The next catalyst is straightforward: May 8, after the close. The question is whether the revenue trajectory shows any deceleration in the deterioration, or whether the 11–12% fourth-quarter decline flagged in the bear case materialises as guided.
See the live data behind this article on ORTEX.
Open HAIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
